CVAT · XBRL financial data

Cavitation Technologies financial statements, every fiscal year

The same tables from 9 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (CVAT's year ends in late June)

In thousands of dollars	FY 2021Jun 30, 2021	FY 2022Jun 30, 2022	FY 2023Jun 30, 2023	FY 2024Jun 30, 2024	FY 2025Jun 30, 2025	FY 2026Jun 30, 2026
Revenue	558	—	433	1,363	203	3
Cost of revenue	20	41	121	156	38	0
Gross profit	538	1,624	312	1,207	165	3
Research and development	21	17	3	61	95	11
General and administrative	1,264	1,728	1,195	708	1,057	1,380
Total operating expenses	1,285	1,923	1,198	769	1,152	1,391
Operating income (loss)	(747)	(299)	(886)	438	(987)	(1,388)
Interest expense	6	5	6	(1)	6	—
Other income (expense)	98	—	—	—	(6)	(40)
Income tax expense (benefit)	0	0	0	—	0	0
Net income (loss)	(649)	(619)	(2,040)	439	(113)	(1,404)
Earnings per share, basic USD per share	0.00	0.00	(0.01)	0.00	0.00	0.00
Earnings per share, diluted USD per share	0.00	0.00	(0.01)	0.00	0.00	0.00
Weighted average shares, basic thousands of shares	197,225	248,736	281,694	284,290	286,001	303,334
Weighted average shares, diluted thousands of shares	197,225	248,736	281,694	284,290	286,001	303,334

Fiscal years (CVAT's year ends in late June)

In thousands of dollars	FY 2021Jun 30, 2021	FY 2022Jun 30, 2022	FY 2023Jun 30, 2023	FY 2024Jun 30, 2024	FY 2025Jun 30, 2025	FY 2026Jun 30, 2026
Cash and cash equivalents	1,363	441	18	179	249	17
Accounts receivable	6	1	0	0	10	0
Inventory	25	48	0	0	—	—
Total current assets	1,394	528	18	195	286	34
Property and equipment, net	182	4	1	0	—	—
Right-of-use asset	245	180	113	42	0	—
Total assets	1,831	1,871	143	248	297	45
Total current liabilities	1,795	558	864	598	102	588
Long-term debt	254	150	145	130	126	150
Lease liability, non-current	193	127	53	0	0	—
Total liabilities	2,242	835	1,062	728	228	738
Accumulated deficit	(24,627)	(25,246)	(27,286)	(26,847)	(26,960)	(28,364)
Total stockholders' equity	(411)	1,036	(919)	(480)	69	(693)
Total liabilities and equity	1,831	1,871	143	248	297	45
Common shares outstanding (cover page) thousands of shares	220,339	276,699	284,290	284,290	289,156	323,820

Fiscal years (CVAT's year ends in late June)

In thousands of dollars	FY 2021Jun 30, 2021	FY 2022Jun 30, 2022	FY 2023Jun 30, 2023	FY 2024Jun 30, 2024	FY 2025Jun 30, 2025	FY 2026Jun 30, 2026
Net income (loss)	(649)	(619)	(2,040)	439	(113)	(1,404)
Depreciation and amortization	22	0	—	—	—	—
Net cash from operating activities	(250)	(484)	(423)	172	(806)	(755)
Purchases of property and equipment	128	—	—	—	—	—
Net cash from investing activities	(128)	(1,223)	0	0	880	0
Proceeds from issuing common stock	728	785	0	—	0	248
Net cash from financing activities	982	785	0	(11)	(4)	523

SIC 700 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.

How peers are chosen

SIC 700 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Fewer than three companies fall in that range, so the list adds same-SIC (700) companies nearest in public float, each marked “added: same SIC”.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Cavitation Technologies	94	0	(128)	324.3M	0.7 quarters	Q1 FY27 10-QSep 30, 2026
RYTHM	41,900	23,021	8,654*	2.2M	—	Q2 FY26 10-QJun 30, 2026
Chase Packaging	181	not reported	(26)*	61.9M	7.0 quarters	Q2 FY26 10-QJun 30, 2026
BNB Standardadded: same SIC	7,084	7,165	(6,475)	41.2M	1.1 quarters	Q1 FY27 10-QJul 31, 2026
Mission Produceadded: same SIC	47,100	450,000	(4,900)*	87.7M	2.4 quarters	Q3 FY26 10-QJul 31, 2026
Calavo Growersadded: same SIC	47,670	122,202	(8,658)	17.9M	5.5 quarters	Q1 FY26 10-QJan 31, 2026
BrightView Holdingsadded: same SIC	14,400	not reported	46,000*	92.6M	—	Q3 FY26 10-QJun 30, 2026
Golden Growers Cooperativeadded: same SIC	95	14,863	(238)*	15.5M	10.1 quarters	Q2 FY26 10-QJun 30, 2026
Inspire Veterinary Partnersadded: same SIC	576	not reported	(1,283)*	3.8M	0.4 quarters	Q3 FY25 10-QSep 30, 2025

Not investment advice. Not affiliated with the U.S. SEC.